ATB logo

Antibiotice S.A. Stock Price

BVB:ATB Community·RON 1.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 19 Fair Values set on narratives written by author

ATB Share Price Performance

RON 2.50
-0.07 (-2.92%)
RON 2.50
-0.07 (-2.92%)
Price RON 2.50

ATB Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with moderate growth potential.

1 Risk
2 Rewards

Antibiotice S.A. Key Details

RON 649.0m

Revenue

RON 245.6m

Cost of Revenue

RON 403.3m

Gross Profit

RON 346.4m

Other Expenses

RON 56.9m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.085
62.15%
8.77%
28.1%
View Full Analysis

About ATB

Founded
1955
Employees
1356
CEO
Ioan Nani
WebsiteView website
www.antibiotice.ro

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for disinfecting surfaces and hands; and veterinary medicines. Its products are available in the form of sterile injectable powders, capsules, tablets, ointments, gels, creams, pessaries, and suppositories. It also provides active pharmaceutical ingredients. The company exports its products to approximately 70 countries. Antibiotice S.A. was founded in 1955 and is headquartered in Iasi, Romania.

Recent ATB News & Updates

Recent updates

No updates